President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing Thursday that, if confirmed as FDA commissioner, he plans to evaluate school lunches,

President Donald Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency, including recent layoffs,

Dr. Marty Makary, Trump's nominee to lead the FDA, said he would review a Biden-era rule that allowed patients to obtain mifepristone without seeing a health care provider in person.

Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration (FDA), appears before the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing on Thursday, March 6, 2025, in Washington, D.C.

The John Hopkins surgeon followed the lead of Robert F. Kennedy Jr. and Jay Bhattacharya in dodging sensitive questions around federal layoffs and agency policy plans.

Dr. Marty Makary, President Trump's pick to run the Food and Drug Administration, faced questions from the Senate HELP Committee on the abortion pill, vaccines, FDA firings and chemicals in food.

Marty Makary wouldn't commit to maintaining current access to mifepristone during his Senate confirmation hearing on Thursday, instead pledging to review the data. Yikes!

Dr. Marty Makary, Trump's nominee for FDA Commissioner, breezed through his confirmation hearing despite tough questions from Democrats and Republicans.

Secretary Robert F. Kennedy Jr. has suggested he is open to restricting access to abortion medication, the primary method used for abortions across the U.S.

Marty Makary, MD, MPH, President Trump's nominee for FDA commissioner, seems likely to be a lock for the position if Thursday's nomination hearing before the Senate Health, Education, Labor & Pensions (HELP) Committee is any indication.

The Wyoming legislature overrode Republican Gov. Mark Gordon's veto on a bill requiring an ultrasound prior to prescribing abortion pills for pregnant women.

President Trump’s pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency, including recent layoffs,